immunosuppression

Open Access
COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?
Michelle Willicombe, David Thomas and Stephen McAdoo

JASN June 2020, 31 (6) 1145-1146; DOI: https://doi.org/10.1681/ASN.2020030348

Add to Selected Citations
Open Access
The Immunocompromised Transplant Recipient and SARS-CoV-2 Infection
Jay A. Fishman

JASN June 2020, 31 (6) 1147-1149; DOI: https://doi.org/10.1681/ASN.2020040416

Add to Selected Citations
You have accessRestricted Access
Early Steroid Withdrawal in Deceased-Donor Kidney Transplant Recipients with Delayed Graft Function
Sunjae Bae, Jacqueline M. Garonzik Wang, Allan B. Massie, Kyle R. Jackson, Mara A. McAdams-DeMarco, Daniel C. Brennan, Krista L. Lentine, Josef Coresh and Dorry L. Segev

JASN January 2020, 31 (1) 175-185; DOI: https://doi.org/10.1681/ASN.2019040416

Add to Selected Citations
You have accessRestricted Access
Tolerogenic Dendritic Cells Attenuate Experimental Autoimmune Antimyeloperoxidase Glomerulonephritis
Dragana Odobasic, Virginie Oudin, Kenji Ito, Poh-Yi Gan, A. Richard Kitching and Stephen R. Holdsworth

JASN November 2019, 30 (11) 2140-2157; DOI: https://doi.org/10.1681/ASN.2019030236

Add to Selected Citations
You have accessRestricted Access
Apoptotic Cell–Induced, Antigen-Specific Immunoregulation to Treat Experimental Antimyeloperoxidase GN
Poh-Yi Gan, Andrea S. Godfrey, Joshua D. Ooi, Kim-Maree O’Sullivan, Virginie Oudin, A. Richard Kitching and Stephen R. Holdsworth

JASN August 2019, 30 (8) 1365-1374; DOI: https://doi.org/10.1681/ASN.2018090955

Add to Selected Citations
You have accessRestricted Access
Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients with Fabry Disease
Malte Lenders and Eva Brand

JASN September 2018, 29 (9) 2265-2278; DOI: https://doi.org/10.1681/ASN.2018030329

Add to Selected Citations
You have accessRestricted Access
Any Progress in the Treatment of Antibody-Mediated Rejection?
Klemens Budde and Michael Dürr

JASN February 2018, 29 (2) 350-352; DOI: https://doi.org/10.1681/ASN.2017121296

Add to Selected Citations
You have accessRestricted Access
Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy
Barbara Seitz-Polski, Hanna Debiec, Alexandra Rousseau, Karine Dahan, Christelle Zaghrini, Christine Payré, Vincent L.M. Esnault, Gérard Lambeau and Pierre Ronco

JASN February 2018, 29 (2) 401-408; DOI: https://doi.org/10.1681/ASN.2017070734

Add to Selected Citations
You have accessRestricted Access
Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy
Thomas Rauen, Christina Fitzner, Frank Eitner, Claudia Sommerer, Martin Zeier, Britta Otte, Ulf Panzer, Harm Peters, Urs Benck, Peter R. Mertens, Uwe Kuhlmann, Oliver Witzke, Oliver Gross, Volker Vielhauer, Johannes F.E. Mann, Ralf-Dieter Hilgers and Jürgen Floege

JASN January 2018, 29 (1) 317-325; DOI: https://doi.org/10.1681/ASN.2017060713

Add to Selected Citations
You have accessRestricted Access
Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children
Agnes Trautmann, Sven Schnaidt, Beata S. Lipska-Ziętkiewicz, Monica Bodria, Fatih Ozaltin, Francesco Emma, Ali Anarat, Anette Melk, Marta Azocar, Jun Oh, Bassam Saeed, Alaleh Gheisari, Salim Caliskan, Jutta Gellermann, Lina Maria Serna Higuita, Augustina Jankauskiene, Dorota Drozdz, Sevgi Mir, Ayse Balat, Maria Szczepanska, Dusan Paripovic, Alexandra Zurowska, Radovan Bogdanovic, Alev Yilmaz, Bruno Ranchin, Esra Baskin, Ozlem Erdogan, Giuseppe Remuzzi, Agnieszka Firszt-Adamczyk, Elzbieta Kuzma-Mroczkowska, Mieczyslaw Litwin, Luisa Murer, Marcin Tkaczyk, Helena Jardim, Anna Wasilewska, Nikoleta Printza, Kibriya Fidan, Eva Simkova, Halina Borzecka, Hagen Staude, Katharina Hees and Franz Schaefer; for the PodoNet Consortium

JASN October 2017, 28 (10) 3055-3065; DOI: https://doi.org/10.1681/ASN.2016101121

Add to Selected Citations

Main menu

User menu

Search

immunosuppression

Pages

About

Author Information

More Information